Received Apr 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | H54F9 | — |
Expired drug administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 11-week-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number H54F9, expiry date 11-APR-2025) for prophylaxis. On 22-APR-2025, the patient received Pediarix. On 22-APR-2025, an unknown time after receiving Pediarix, the patient experienced expired vaccine used (Verbatim: Expired drug administered). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 23-APR-2025 Nurse reported that Pediarix was administered to a baby but the dose was expired, which led to expired vaccine used. HCP was going to consider this dose valid and proceed with the regular schedule. The reporter consented to follow up. The Vaccine Administration Facility was the same as Primary Reporter.